Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. 303-227-1
Published by: IBS Case Development Center
Published in: 2003

Abstract

The major driver of the pharmaceutical industry is R&D. While research and innovation costs increase, companies become pressured to improve R&D productivity. To leverage investments and research positions, companies turn to mergers and acquisitions. But consolidation saw R&D productivity decelerate. The industry became increasingly dependent on blockbuster drugs. Most blockbusters that emerged were cardiovascular drugs. Statins were certain chemicals which belonged to this class. Lipitor, a statin, was discovered and developed by Warner Lambert and quickly became a blockbuster and the best selling drug of all time. The case discusses the importance of blockbusters in the current pharma industry and the path of Lipitor''s emergence as a megabrand.
Location:
Industry:
Other setting(s):
2003

About

Abstract

The major driver of the pharmaceutical industry is R&D. While research and innovation costs increase, companies become pressured to improve R&D productivity. To leverage investments and research positions, companies turn to mergers and acquisitions. But consolidation saw R&D productivity decelerate. The industry became increasingly dependent on blockbuster drugs. Most blockbusters that emerged were cardiovascular drugs. Statins were certain chemicals which belonged to this class. Lipitor, a statin, was discovered and developed by Warner Lambert and quickly became a blockbuster and the best selling drug of all time. The case discusses the importance of blockbusters in the current pharma industry and the path of Lipitor''s emergence as a megabrand.

Settings

Location:
Industry:
Other setting(s):
2003

Related